A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.

Why are some filings missing?

New filings appear as the SEC updates EDGAR, and older records can vary by availability.

How often is this page updated?

Updates follow new EDGAR submissions and periodic data refreshes.

SEC EDGAR filings, ownership reports, and insider transactions for Salvatore Calabrese.

Business address: C/O Gain Therapeutics, Inc., 4800 Hampden Lane, Suite 200, Bethesda, MD, 20814
Top holdings (ownership): GANX

Get insider transactions for this reporting owner

Salvatore Calabrese has filed 5 SEC EDGAR filings since 29 Mar 2021

Recent SEC filings for Salvatore Calabrese including 4, 4/A, 3.

Form type	Document	Filing	Description	Filing date	Reporting date	File number(s)
4	Open 4 document	View SEC filing for 4	FORM 4 SUBMISSION	27 Mar 2023	23 Mar 2023	001-40237
4	Open 4 document	View SEC filing for 4	FORM 4 SUBMISSION	19 Jul 2022	15 Jul 2022	001-40237
4/A	Open 4/A document	View SEC filing for 4/A		23 May 2022	19 May 2022	001-40237
4	Open 4 document	View SEC filing for 4		19 May 2022	19 May 2022	001-40237
3	Open 3 document	View SEC filing for 3	FORM 3	29 Mar 2021	17 Mar 2021	001-40237

Salvatore Calabrese files with the SEC under CIK 0001851958. This page aggregates EDGAR filings and related ownership activity.

What is a CIK?: A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?: New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?: Updates follow new EDGAR submissions and periodic data refreshes.